8th ESO-ESMO Masterclass in Clinical Oncology

Aims and objectives
This clinically oriented educational programme has been designed for dedicated oncologists who wish to improve
their skills or those who are preparing for the national board exam. The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training. The programme focuses on breast, colorectal, gynaecological, head and neck, lung cancers and other thoracic malignancies. Spotlight sessions will facilitate compact update on haematological diseases, renal cell cancer, testicular cancer, supportive care, immunotherapy, cancer and pregnancy, adolescent patients, and long-term survivorship.

Teaching format
The Masterclass offers plenary lectures with state-of-the-art treatments with reference to clinical guidelines and which will conclude in take-home messages. Participants will deliver case presentations within small groups and discuss these with the chair and the faculty. All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will join selected medical sessions.

ACCREDITATION
Application for CME recognition will be submitted to the Accreditation Council for Oncology in Europe, whilst the event has been accredited with 25 category 1 ESMO-MORA points.

The Masterclass is part of the Sharing Progress in Cancer Care programme whose sustaining members are:Amgen, AstraZeneca, Eli Lilly, GlaxoSmithKline Oncology, Merck and Novartis.

The Masterclass is:
- A one-week residential educational event
- Full immersion
- Clinically-oriented
- Multidisciplinary
- An international faculty of top experts delivering lectures focusing on breast, colorectal, gynaecological, head and neck, urological and lung cancers

FACULTY

M. Aapro, IMO Clinique de Genolier, FMH Oncologie-Hématologie, Genolier, CH
J. Bernier, Genolier Swiss Medical Network, Dept. of Radiotherapy, Genolier, CH
S. Bracarda, Ospedale S. Maria della Misericordia, Dept. of Medical Oncology, Perugia,IT
F. Cardoso, Jules Bordet Institute, Medical Oncology Clinic, Brussels, BE
M. Cullen, University Hospital Birmingham, Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK
L. Denis, Oncology Center Antwerp,  Antwerp, BE
T. Eisen, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
M. Fey, Universitäts für Medizinische Onkologie, Inselspital, Bern, CH
W. Gatzemeier, Istituto Clinico Humanitas, Breast Unit, Rozzano-Milano, IT
M. Ghielmini, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, CH
R. Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Consultant Clinical Oncologist, Northwood, UK
S. Junius, University Hospital Gasthuisberg, Dept. of Radiation Oncology, Leuven, BE
J.L. Lefèbvre, Institut Centre Oscar Lambret, Head and Neck Department, Lille, FR
J. Maher, Macmillan Cancer Support, Chief Medical Officer, London, UK
A. Padhani, Mount Vernon Hospital, Paul Strickland Scanner Center, Northwood, UK
O. Pagani, Oncology Institute of Southern Switzerland, Dept. of Medical Oncology, Lugano,CH
N. Pavlidis, University of Ioannina, Div. of Medical Oncology, Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, CH
C. J.A. Punt, University Medical Center St. Radboud, Dept. of Medical Oncology, Nijmegen, NL
N. Reed, Beatson Oncology Centre, Western Infirmary, Glasgow, UK
L. Rowett, ESMO Executive Director – Annals of Oncology, Oxford, UK
T. Seufferlein, Martin-Luther-University Halle-Wittenberg, Dept. of Internal Medicine I, Halle, DE
R. Stahel, University Hospital Zürich, Clinic and Policlinic for Oncology, Zurich, Switzerland, CH
I. Taylor, Royal Free & University College Medical School, Dept. of Surgery, London, UK
E. Van Cutsem, University Hospital Gasthuisberg, Dept. Internal Medicine - Digestive Oncology Unit, Leuven, Belgium, BE
P. Van Houtte, Institut Jules Bordet, Dept. of Radiation Oncology, Bruxelles, Belgium, BE
P. Van Schil, University Hospital of Antwerp, Dept. of Thoracic and Vascular Surgery, Edegem, Belgium, BE
V.M. Veloso, Portugal Institute of Oncology, Dept. of Surgery, Porto, Portugal, PL
J. Vermorken, University Hospital Antwerp, Dept. of Oncology, Edegem, Belgium, BE
G. Viale, European Institute of Oncology, Dept. of Pathology, and University of Milan, Milano, IT
J. Whelan, University College London Hospital, Dept. of Oncology, London, UK
H. Wildiers, University Hosptial Gasthuisberg, Dept. of Medical Oncology, Leuven, Belgium, BE

21 March

22 March

23 March

24 March

25 March

26 March